You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Unfit for Chemotherapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroendocrine Tumors, Frailty, Chemo Effect Trial in Milan (Temozolomide capsule)

Recruiting
  • Neuroendocrine Tumors
  • +2 more
  • Temozolomide capsule
  • Milan, Italy
    European Institute of Oncology, IEO, IRCCS
Sep 21, 2022

NSCLC, Stage III Trial in Germany (Durvalumab Injection [Imfinzi], Thoracic Radiotherapy (TRT) conventionally, Thoracic

Recruiting
  • NSCLC, Stage III
  • Durvalumab Injection [Imfinzi]
  • +2 more
  • Aachen, Germany
  • +13 more
Nov 29, 2022

AML, Adult Trial in Chicago, Charlottesville (BST-236, venetoclax)

Recruiting
  • AML, Adult
  • Chicago, Illinois
  • +1 more
Aug 17, 2022

Acute Myeloid Leukemia Trial in Firenze (Venetoclax+Decitabine)

Recruiting
  • Acute Myeloid Leukemia
  • Firenze, Italy
    Az. Ospedaliero - Universitaria Careggi
Jan 3, 2022

Pancreatic Cancer Non-resectable Trial in Amsterdam, Utrecht (stereotactic ablative radiotherapy)

Recruiting
  • Pancreatic Cancer Non-resectable
  • stereotactic ablative radiotherapy
  • Amsterdam, Noord-Holland, Netherlands
  • +1 more
Feb 22, 2022

Penile Cancer, Advanced Cancer, Metastatic Cancer Trial in Toronto (Avelumab, Best Supportive Care)

Recruiting
  • Penile Cancer
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Nov 26, 2021

Locally Advanced Lung Non-Small Cell Carcinoma Trial in Terni (Stereotactic Ablative Radiotherapy in Unresectable Locally

Completed
  • Locally Advanced Lung Non-Small Cell Carcinoma
  • Stereotactic Ablative Radiotherapy in Unresectable Locally Advanced Non-Small Cell Lung Cancer
  • Terni, TR, Italy
    Radiotherapy Oncology Centre "S.Maria" Hospital
Mar 22, 2022

Acute Myeloid Leukemia Trial in Baltimore (Decitabine, talazoparib)

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia
  • Baltimore, Maryland
    University of Maryland Greenebaum Comprehensive Cancer Center
May 31, 2022

Acute Myeloid Leukemia Trial in United States (CPX-351, Venetoclax)

Completed
  • Acute Myeloid Leukemia
  • Duarte, California
  • +7 more
Nov 7, 2022

MDS, Acute Myeloid Leukemia Trial in France (BST-236)

Recruiting
  • Myelodysplastic Syndromes
  • Acute Myeloid Leukemia
  • Amiens, France
  • +16 more
Jan 2, 2023

Acute Myeloid Leukemia Trial in Worldwide (MBG453, Venetoclax, Azacitidine)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Birmingham, Alabama
  • +27 more
Jan 20, 2023

AML, Adult, MDS, Relapse/Recurrence Trial in United States (BST-236)

Recruiting
  • AML, Adult
  • +3 more
  • Shreveport, Louisiana
  • +3 more
Jul 19, 2022

Leukemia, Myeloid, Acute Trial (The combination of HHT, venetoclax, AZA, G-CSF)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • The combination of HHT, venetoclax, AZA, G-CSF
  • (no location specified)
Mar 28, 2021

ACUTE MYELOID LEUKEMIA Trial in New Haven (Glasdegib, Decitabine)

Terminated
Has Results
  • ACUTE MYELOID LEUKEMIA
  • New Haven, Connecticut
    Yale Cancer Center/Smilow
Sep 18, 2021

Acute Myeloid Leukemia Trial in United States (Quizartinib, Milademetan)

Terminated
Has Results
  • Acute Myeloid Leukemia
  • Los Angeles, California
  • +7 more
Mar 14, 2022

Acute Myeloid Leukemia Trial in France (GRASPA)

Completed
Has Results
  • Acute Myeloid Leukemia
  • Nice, Alpes Maritimes, France
  • +20 more
Feb 18, 2022

Acute Myeloid Leukemia, in Relapsed or Refractory, Acute Myeloid Leukemia, Elderly, Unfit, Acute Myeloid Leukemia With Positive

Unknown status
  • Acute Myeloid Leukemia, in Relapsed or Refractory
  • +2 more
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Sep 8, 2020

Unfit AML Patients Treated With Combination Venetoclax Plus

Recruiting
  • Acute Myeloid Leukemia
  • Venetoclax plus HMA
  • Bergamo, Italy
  • +22 more
Oct 10, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Secondary Acute Myeloid Leukemia

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Greenwich, Connecticut
  • +27 more
Dec 30, 2022

Leukemia, Myeloid, Acute Trial in Portugal, Spain (Pevonedistat, Azacitidine)

Active, not recruiting
  • Leukemia, Myeloid, Acute
  • Coimbra, Portugal
  • +63 more
Sep 9, 2022

Acute Myeloid Leukemia (Relapsed/Refractory) Trial in Suzhou (Selinexor, Chidamide)

Recruiting
  • Acute Myeloid Leukemia (Relapsed/Refractory)
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Jul 16, 2023

Pancreas Cancer, Non-Resectable Pancreas Carcinoma Trial in Aalborg (Gemcitabine, Nab paclitaxel)

Not yet recruiting
  • Pancreas Cancer
  • Non-Resectable Pancreas Carcinoma
  • Aalborg, Denmark
    Department of Oncology, Aalborg University Hospital
May 1, 2023

Urothelial Bladder Carcinoma Trial in Spain (Sacituzumab govitecan, Zimberelimab, Domvanalimab)

Not yet recruiting
  • Urothelial Bladder Carcinoma
  • Sacituzumab govitecan
  • +2 more
  • Santiago De Compostela, A Coruña, Spain
  • +9 more
Nov 14, 2023

MDS, Acute Myeloid Leukemia Trial (Sabatolimab, Magrolimab, Azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Acute Myeloid Leukemia
  • (no location specified)
Sep 2, 2022

Diffuse Large B-cell Lymphoma Trial in Worldwide (Mosunetuzumab Intravenous (IV), Mosunetuzumab Subcutaneous (SC), Polatuzumab

Recruiting
  • Diffuse Large B-cell Lymphoma
  • Mosunetuzumab Intravenous (IV)
  • +3 more
  • Birmingham, Alabama
  • +52 more
Aug 19, 2022